Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scholar Rock IncfiledCriticalScholar Rock Inc
Publication of AR115756A1publicationCriticalpatent/AR115756A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
En el presente documento se describen anticuerpos monoclonales y fragmentos de unión a antígeno de los mismos capaces de inhibir selectivamente TGFb1. También se describen composiciones relacionadas, métodos y uso terapéutico.Monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGF-1 are described herein. Related compositions, methods, and therapeutic use are also described.
ARP190101956A2018-07-112019-07-11
TGFb1 INHIBITORS AND USE OF THEM
AR115756A1
(en)